AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Ingevity Corporation

$69.41 +$9.32 (+15.51%)
NYSE · 11 Sep 2026 20:00 UTC
Previous Close
$67.13
Day Range
$68.01$70.2
Year Range
$45.85$79.29
Market Cap
2.39B
AVG Volume
257.66K
Trailing/Forward PE
45.07/11.48
PEG ratio
3.52
Dividend Yield
-
Next Earnings Date
2026-11-04
Primary Exchange
New York Stock ExchangeUS
Revenue (USD) · TTM
0500M1B1.5B2B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NGVT Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
26 Q21.16B
26 Q11.21B
25 Q41.24B
25 Q31.28B
25 Q21.32B
25 Q11.35B
24 Q41.41B
24 Q31.48B
24 Q21.55B
24 Q11.64B
Net Income (USD) · TTM
-600M-400M-200M0200M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NGVT Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
26 Q254M
26 Q1-127.8M
25 Q4-167.1M
25 Q3-65.9M
25 Q2-216.6M
25 Q1-353.8M
24 Q4-430.3M
24 Q3-563.7M
24 Q2-431.3M
24 Q1-112.1M
Operating Income (USD) · TTM
0100M200M300M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NGVT Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
26 Q2250.7M
26 Q1276.5M
25 Q4270.1M
25 Q3286.5M
25 Q2288.2M
25 Q1276.8M
24 Q4259.9M
24 Q3213.6M
24 Q2129.1M
24 Q1146.7M
EBITDA (USD) · TTM
-600M-400M-200M0200M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NGVT EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
26 Q2191.5M
26 Q117.1M
25 Q420.8M
25 Q3141.1M
25 Q2-51.9M
25 Q1-238M
24 Q4-329.5M
24 Q3-491.8M
24 Q2-318.5M
24 Q171.2M
Cash Flows (USD) · TTM
0100M200M300M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NGVT Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
26 Q2154.9M
26 Q1245.8M
25 Q4273.5M
25 Q3239.6M
25 Q2150.3M
25 Q195.1M
24 Q451M
24 Q326.8M
24 Q270M
24 Q185.1M
EPS (USD) · TTM
-20-15-10-50524 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NGVT EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
26 Q21.47
26 Q1-3.55
25 Q4-4.65
25 Q3-1.83
25 Q2-5.96
25 Q1-9.75
24 Q4-11.85
24 Q3-15.53
24 Q2-11.89
24 Q1-3.11
Expenses (USD) · TTM
0100M200M300M400MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NGVT Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
26 Q2248.7M
26 Q1257.5M
25 Q4260.6M
25 Q3259.6M
25 Q2260M
25 Q1262.6M
24 Q4272.4M
24 Q3280.6M
24 Q2298.5M
24 Q1302.6M
Shares Outstanding (USD) · TTM
-50M050M100M150MBuybacks (Repurchases)Stock-Based Compensation24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NGVT Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
26 Q2124.3M
26 Q189.6M
25 Q438M
25 Q39.3M
25 Q2-13.7M
25 Q1-11.7M
24 Q4-11.9M
24 Q3-12.1M
24 Q2-8.1M
24 Q148.1M
Employee Count
01K2K3K2016201720182019202020212022202320242025
NGVT Employee Count by quarter
PeriodEmployee Count
20251.5K
20241.6K
20231.7K
20222.05K
20211.85K
20201.75K
20191.85K
20181.75K
20171.5K
20161.5K
PE Ratio
0204060med 12.82Jul 22Oct 22Feb 23May 23Sep 23Dec 23Sep 26
NGVT PE Ratio by quarter
PeriodPE Ratio
Sep 2644.99
Sep 2645.72
Aug 2645
Aug 2645.55
Aug 2649.76
Aug 2650.44
Jul 2647.39
Feb 2413.59
Feb 2412.79
Feb 2412.49
Jan 2413.09
Jan 2411.65
Jan 2411.82
Jan 2412.35
Dec 2313.47
Dec 2313.64
Dec 2313.06
Dec 2311.91
Dec 2311.61
Nov 2311.35
Nov 2311.45
Nov 2310.82
Nov 2312.21
Oct 238.11
Oct 238.33
Oct 238.29
Oct 238.67
Sep 239.77
Sep 239.62
Sep 2310.4
Sep 2310.29
Sep 2311.22
Aug 2310.59
Aug 2310.6
Aug 2310.86
Aug 2311.94
Jul 2311.69
Jul 2311.36
Jul 2311.11
Jul 2310.81
Jun 2310.73
Jun 239.58
Jun 2310.03
Jun 239.94
Jun 239.56
May 239.2
May 239.33
May 2310.05
May 2311.17
Apr 2312.68
Apr 2312.59
Apr 2312.85
Apr 2312.29
Mar 2312.64
Mar 2312.21
Mar 2312.18
Mar 2312.62
Mar 2314.44
Feb 2314.87
Feb 2315.24
Feb 2314.75
Feb 2314.6
Jan 2313.5
Jan 2313.52
Jan 2313.71
Jan 2312.45
Dec 2211.83
Dec 2211.86
Dec 2211.66
Dec 2212.09
Dec 2213.03
Nov 2213.17
Nov 2212.93
Nov 2213.22
Nov 2212.49
Oct 2217.52
Oct 2217.12
Oct 2216.23
Oct 2216.41
Sep 2216.03
Sep 2216.22
Sep 2216.93
Sep 2218.59
Sep 2218.35
Aug 2219.04
Aug 2219.31
Aug 2219.85
Aug 2218.17
Jul 2220.1
Jul 2218.95
Jul 2218.51
Jul 2219.08
Jul 2219.02
Jun 2219.19
Jun 2218.4
Jun 2221.14
Jun 2221.69
May 2221.05
May 2220.25
May 2219.71
Free Cash Flow Yield
0%5%10%15%med 6.99%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
NGVT Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 266.38%
Sep 266.27%
Aug 266.37%
Aug 266.3%
Aug 265.76%
Aug 265.69%
Jul 266.05%
Jul 269.5%
Jul 269.1%
Jul 269.66%
Jul 269.61%
Jun 269.03%
Jun 269.49%
Jun 269.67%
Jun 2610.55%
May 2610.27%
May 2610.44%
May 2610.3%
May 269.21%
May 2610.09%
Apr 2610.03%
Apr 2610.19%
Apr 2610.18%
Apr 2610.78%
Mar 2610.86%
Mar 2612.04%
Mar 2611.86%
Mar 2611.8%
Feb 2610.64%
Feb 269.14%
Feb 268.62%
Feb 269.08%
Jan 2610.03%
Jan 269.51%
Jan 269.98%
Jan 2610.24%
Jan 2610.98%
Dec 2510.97%
Dec 2511.26%
Dec 2511.21%
Dec 2512.48%
Nov 2512.64%
Nov 2513.32%
Nov 2513.37%
Nov 2513.64%
Oct 257.69%
Oct 257.22%
Oct 257.6%
Oct 257.81%
Oct 257.51%
Sep 257.49%
Sep 257.33%
Sep 257.1%
Sep 256.91%
Aug 257.07%
Aug 257.15%
Aug 257.57%
Aug 258.05%
Aug 256.47%
Jul 255.63%
Jul 255.66%
Jul 255.49%
Jul 255.59%
Jun 256.03%
Jun 256.32%
Jun 256.22%
Jun 256.21%
May 256.32%
May 256.39%
May 256.08%
May 256.46%
May 254.01%
Apr 254.27%
Apr 254.45%
Apr 254.4%
Apr 254.47%
Mar 253.55%
Mar 253.32%
Mar 253.2%
Mar 252.97%
Feb 252.95%
Feb 253.05%
Feb 251.63%
Feb 251.73%
Jan 251.63%
Jan 251.57%
Jan 251.56%
Jan 251.94%
Jan 251.85%
Dec 241.82%
Dec 241.81%
Dec 241.61%
Dec 241.57%
Nov 241.52%
Nov 241.52%
Nov 241.6%
Nov 241.63%
Nov 241.76%
Oct 245.73%
Oct 245.54%
Price to Sales
0.511.522.5med 1.5Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
NGVT Price to Sales by quarter
PeriodPrice to Sales
Sep 262.09
Sep 262.13
Aug 262.09
Aug 262.12
Aug 262.32
Aug 262.35
Jul 262.21
Jul 262.13
Jul 262.23
Jul 262.1
Jul 262.11
Jun 262.25
Jun 262.14
Jun 262.1
Jun 261.92
May 261.98
May 261.94
May 261.97
May 262.2
May 262.19
Apr 262.2
Apr 262.17
Apr 262.17
Apr 262.05
Mar 262.04
Mar 261.84
Mar 261.86
Mar 261.87
Feb 262.08
Feb 262.05
Feb 262.17
Feb 262.06
Jan 261.86
Jan 261.97
Jan 261.88
Jan 261.83
Jan 261.7
Dec 251.7
Dec 251.66
Dec 251.67
Dec 251.5
Nov 251.48
Nov 251.4
Nov 251.4
Nov 251.37
Oct 251.48
Oct 251.57
Oct 251.49
Oct 251.45
Oct 251.51
Sep 251.51
Sep 251.55
Sep 251.6
Sep 251.64
Aug 251.6
Aug 251.59
Aug 251.5
Aug 251.41
Aug 251.09
Jul 251.25
Jul 251.24
Jul 251.28
Jul 251.26
Jun 251.17
Jun 251.11
Jun 251.13
Jun 251.13
May 251.12
May 251.1
May 251.16
May 251.09
May 250.9
Apr 250.85
Apr 250.82
Apr 250.82
Apr 250.81
Mar 251.02
Mar 251.09
Mar 251.13
Mar 251.22
Feb 251.23
Feb 251.19
Feb 251.11
Feb 251.05
Jan 251.11
Jan 251.15
Jan 251.16
Jan 250.93
Jan 250.98
Dec 241
Dec 241
Dec 241.13
Dec 241.16
Nov 241.19
Nov 241.19
Nov 241.13
Nov 241.11
Nov 241.03
Oct 240.79
Oct 240.82
EV/EBITDA
0100200300med 21.14Sep 23Dec 23Apr 24Jul 24Feb 26May 26Sep 26
NGVT EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2618.63
Sep 2618.84
Aug 2618.64
Aug 2618.79
Aug 2619.98
Aug 2620.17
Jul 2619.31
Jul 26218.44
Jul 26225.19
Jul 26215.99
Jul 26216.85
Jun 26226.41
Jun 26218.75
Jun 26215.8
Jun 26203.44
May 26207.21
May 26204.84
May 26206.72
May 26223.34
May 26186.3
Apr 26187.14
Apr 26185.06
Apr 26185.15
Apr 26178.01
Mar 26177.11
Mar 26165.18
Mar 26166.88
Mar 26167.47
Feb 26179.62
Feb 2627.13
Feb 2628.26
Feb 2627.26
Jan 2625.49
Jan 2626.43
Jan 2625.59
Jan 2625.14
Jan 2624.02
Dec 2524.04
Dec 2523.64
Dec 2523.71
Dec 2522.17
Nov 2522
Nov 2521.31
Nov 2521.26
Nov 2521.01
Jul 2444.16
Jul 2443.26
Jul 2443.15
Jul 2441.66
Jun 2442.89
Jun 2442.99
Jun 2443.5
Jun 2445.1
May 2445.51
May 2444.94
May 2447.9
May 2448.38
May 2447.91
Apr 2415.51
Apr 2414.79
Apr 2414.94
Apr 2415.16
Mar 2415.37
Mar 2415.31
Mar 2414.94
Mar 2415.07
Mar 2414.94
Feb 2415.59
Feb 248.47
Feb 248.2
Feb 248.1
Jan 248.3
Jan 247.81
Jan 247.87
Jan 248.05
Dec 238.43
Dec 238.48
Dec 238.29
Dec 237.9
Dec 237.8
Nov 237.71
Nov 237.75
Nov 237.53
Nov 238
Oct 236.92
Oct 237.01
Oct 237
Oct 237.15
Sep 237.61
Sep 237.55
Sep 237.87
Sep 237.82
Sep 238.21
Aug 237.95
Aug 237.95
Aug 238.06
Aug 238.51
Jul 238.7
Jul 238.55
Jul 238.44
Price/Operating Cashflow
5101520med 9.13Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
NGVT Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 2611.51
Sep 2611.7
Aug 2611.52
Aug 2611.66
Aug 2612.73
Aug 2612.91
Jul 2612.13
Jul 268.51
Jul 268.89
Jul 268.37
Jul 268.42
Jun 268.96
Jun 268.53
Jun 268.36
Jun 267.67
May 267.88
May 267.75
May 267.85
May 268.79
May 268.18
Apr 268.24
Apr 268.11
Apr 268.11
Apr 267.66
Mar 267.61
Mar 266.86
Mar 266.96
Mar 267
Feb 267.76
Feb 268.78
Feb 269.31
Feb 268.84
Jan 268
Jan 268.44
Jan 268.04
Jan 267.83
Jan 267.3
Dec 257.31
Dec 257.13
Dec 257.16
Dec 256.43
Nov 256.35
Nov 256.02
Nov 256
Nov 255.88
Oct 259.08
Oct 259.66
Oct 259.18
Oct 258.93
Oct 259.3
Sep 259.31
Sep 259.52
Sep 259.83
Sep 2510.1
Aug 259.87
Aug 259.77
Aug 259.22
Aug 258.66
Aug 258.85
Jul 2510.17
Jul 2510.12
Jul 2510.42
Jul 2510.25
Jun 259.5
Jun 259.05
Jun 259.21
Jun 259.22
May 259.07
May 258.96
May 259.41
May 258.87
May 259.89
Apr 259.28
Apr 258.91
Apr 259.02
Apr 258.87
Mar 2511.18
Mar 2511.96
Mar 2512.41
Mar 2513.37
Feb 2513.45
Feb 2512.99
Feb 2515.08
Feb 2514.25
Jan 2515.16
Jan 2515.68
Jan 2515.78
Jan 2512.71
Jan 2513.33
Dec 2413.58
Dec 2413.64
Dec 2415.32
Dec 2415.75
Nov 2416.24
Nov 2416.24
Nov 2415.37
Nov 2415.13
Nov 2414.04
Oct 247.3
Oct 247.54
Price to Book
0255075100med 15.63Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
NGVT Price to Book by quarter
PeriodPrice to Book
Sep 2651.8
Sep 2652.64
Aug 2651.81
Aug 2652.44
Aug 2657.29
Aug 2658.07
Jul 2654.56
Jul 2666.48
Jul 2669.45
Jul 2665.4
Jul 2665.78
Jun 2669.98
Jun 2666.62
Jun 2665.32
Jun 2659.88
May 2661.54
May 2660.5
May 2661.33
May 2668.63
May 2691.26
Apr 2691.85
Apr 2690.39
Apr 2690.45
Apr 2685.45
Mar 2684.83
Mar 2676.47
Mar 2677.66
Mar 2678.07
Feb 2686.58
Feb 2618.98
Feb 2620.13
Feb 2619.11
Jan 2617.29
Jan 2618.25
Jan 2617.39
Jan 2616.94
Jan 2615.79
Dec 2515.81
Dec 2515.41
Dec 2515.47
Dec 2513.91
Nov 2513.73
Nov 2513.03
Nov 2512.98
Nov 2512.72
Oct 2516.2
Oct 2517.24
Oct 2516.38
Oct 2515.94
Oct 2516.59
Sep 2516.62
Sep 2516.99
Sep 2517.54
Sep 2518.03
Aug 2517.61
Aug 2517.43
Aug 2516.46
Aug 2515.46
Aug 256.27
Jul 257.2
Jul 257.16
Jul 257.38
Jul 257.26
Jun 256.73
Jun 256.41
Jun 256.52
Jun 256.52
May 256.42
May 256.34
May 256.66
May 256.28
May 256.52
Apr 256.11
Apr 255.87
Apr 255.94
Apr 255.84
Mar 257.37
Mar 257.88
Mar 258.17
Mar 258.81
Feb 258.86
Feb 258.56
Feb 257.64
Feb 257.22
Jan 257.68
Jan 257.95
Jan 258
Jan 256.44
Jan 256.75
Dec 246.88
Dec 246.91
Dec 247.77
Dec 247.98
Nov 248.23
Nov 248.23
Nov 247.79
Nov 247.67
Nov 247.12
Oct 244.29
Oct 244.43
Ingevity Corporation
NGVT
Stockpicker

Video analysis: NGVT

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: NGVT

Ingevity Shares Rise 19.2% YTD: Can the Stock Sustain the Rally?

zacks.com · 8 Sep 2026

Ingevity Shares Rise 19.2% YTD: Can the Stock Sustain the Rally?

NGVT's 19.2% YTD rally is backed by portfolio optimization, stronger hybrid demand, pricing gains and higher margins, fueling earnings growth.

Ingevity CEO Dave Li and CFO Phil Platt to speak at 2026 Jefferies Global Industrials Conference

businesswire.com · 3 Sep 2026

Ingevity CEO Dave Li and CFO Phil Platt to speak at 2026 Jefferies Global Industrials Conference

NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity will participate in a fireside chat during the 2026 Jefferies Industrials Conference.

Canada Pension Plan Investment Board Makes New Investment in Ingevity Corporation $NGVT

defenseworld.net · 1 Sep 2026

Canada Pension Plan Investment Board Makes New Investment in Ingevity Corporation $NGVT

Canada Pension Plan Investment Board purchased a new stake in Ingevity Corporation (NYSE: NGVT) in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 14,900 shares of the company's stock, valued at approximately $1,113,000. Several other institutional investors have also recently made changes to

Ingevity (NGVT) Down 0.6% Since Last Earnings Report: Can It Rebound?

zacks.com · 28 Aug 2026

Ingevity (NGVT) Down 0.6% Since Last Earnings Report: Can It Rebound?

Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock?

Ingevity: Portfolio Simplification Reveals A High-Margin Regulatory Compounder

seekingalpha.com · 28 Aug 2026

Ingevity: Portfolio Simplification Reveals A High-Margin Regulatory Compounder

Ingevity is transforming into a focused, high-margin regulatory compounder, emphasizing Performance Materials and Pavement Technologies after divesting volatile, lower-quality segments. Q2 '26 results highlight margin inflection: adjusted EBITDA rose 14% to $115M, margin expanded to 36.6%, and EPS increased to $1.74, demonstrating strong operating leverage. Hybrid vehicle adoption and infrastructure spending underpin resilient demand for NGVT's emissions-control and pavement solutions, while PFAS filtration offers incremental EBITDA growth optionality.

Why You Should Add Ingevity Stock to Your Portfolio Now

zacks.com · 26 Aug 2026

Why You Should Add Ingevity Stock to Your Portfolio Now

NGVT's raised 2026 outlook, portfolio transformation and new growth platforms support its momentum and higher-return investment focus.

Ingevity included in TIME America's Best Companies 2026 list

businesswire.com · 18 Aug 2026

Ingevity included in TIME America's Best Companies 2026 list

NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity included in TIME America's Best Companies 2026 list.

NGVT Q2 Earnings Beat on Pricing, Mix and Higher Volumes

zacks.com · 6 Aug 2026

NGVT Q2 Earnings Beat on Pricing, Mix and Higher Volumes

Ingevity's Q2 earnings beat estimates as pricing, mix and higher volumes lifted margins, prompting higher 2026 earnings and EBITDA guidance.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.